Chevron Paraquat Lawsuit

Chevron's role as U.S. distributor

For decades, Chevron U.S.A. distributed paraquat in the United States under the Gramoxone brand through arrangements with ICI (now Syngenta) and its corporate predecessors. As a distributor, Chevron shares product liability with the manufacturer for the period it placed paraquat into the U.S. market. That liability persists today — it is not extinguished by the passage of time or by Chevron's eventual exit from the distribution arrangement.

Why distributor liability matters

Product liability law in most U.S. states extends to every entity in the chain of distribution: the manufacturer, distributors, and sometimes retailers. The reason is straightforward — consumers and workers should not have to identify which corporate entity in a long supply chain caused their injury when all participants benefited from putting an inadequately warned product into commerce.

For paraquat plaintiffs, distributor liability has three practical consequences:

• Chevron is a separate co-defendant. The April 2025 Syngenta settlement framework does not bind Chevron. Cases involving exposure during Chevron's distribution period have an additional defendant with independent settlement authority.
• Chevron's resources are independent. Chevron is a major U.S. corporation with substantial assets and a sophisticated litigation function. Chevron's settlement posture is independent of ChemChina-owned Syngenta's posture.
• Jurisdictional reach. Chevron's U.S. corporate footprint creates personal jurisdiction in many forums that may be more difficult to establish over Swiss-headquartered Syngenta.

Gramoxone brand history

Gramoxone was the original commercial paraquat product. The brand has been the dominant U.S. paraquat label for decades. Many farmworkers and applicators know only the Gramoxone name, not paraquat or its generic chemistry. For litigation purposes, brand recall of "Gramoxone" maps cleanly to the paraquat exposure history that supports a claim.

Other paraquat brand names — Blanco, Devour, Firestorm, Helmquat, Para-Shot 30, Parazone, Tota-col — all involve the same active ingredient (paraquat dichloride) and all support paraquat Parkinson's claims regardless of brand name recalled.

Chevron's litigation posture

Chevron has historically defended distributor liability cases aggressively, often arguing that distributor knowledge of risk was limited to what manufacturers disclosed at the time. Plaintiffs' counsel respond with the body of public scientific literature on paraquat and Parkinson's that was available throughout Chevron's distribution period — literature that put any reasonable distributor on inquiry notice.

The April 2025 Syngenta settlement framework does not address Chevron's exposure. Pennsylvania state court cases that proceed against both defendants have independent settlement leverage against Chevron.

What this means for your claim

If your paraquat exposure occurred during the period Chevron distributed Gramoxone in the United States — which spans much of the modern paraquat use history — Chevron will be named as a co-defendant alongside Syngenta. Your settlement or trial outcome may involve recovery from both defendants under independent theories of liability.

Related: Syngenta Liability, Litigation Overview, Check Eligibility